Literature DB >> 18816699

Applying diagnostic criteria for type 1 von Willebrand disease to a pediatric population.

Sarah A Hyatt1, Wei Wang, Bryce A Kerlin, Sarah H O'Brien.   

Abstract

BACKGROUND: Definitive diagnosis of type 1 von Willebrand disease (VWD) remains elusive in clinical practice. Both the International Society on Thrombosis and Haemostasis (ISTH) and the Hospital for Sick Children (HSC) have proposed diagnostic criteria for type 1 VWD, which include abnormal laboratory values, significant mucocutaneous bleeding history, and/or positive family history. The objective of this study was to apply ISTH and HSC criteria to a large pediatric population previously diagnosed with type 1 VWD. We hypothesized that a substantial number of patients would not meet these diagnostic criteria. PROCEDURE: We performed a retrospective medical record review of all type 1 VWD patients at a single children's hospital. Frequencies of fit for ISTH and HSC diagnostic criteria were calculated.
RESULTS: Of 201 patients, 4.5% and 34% met the ISTH and HSC definitions, respectively. An additional 15% (ISTH) and 56% (HSC) met the definition of possible disease. For each definition, criteria for significant bleeding were most likely to be met, while criteria for abnormal laboratory values were least likely. When defined as simply VWF:Ag 5-20 IU/ml, as recently proposed by the ISTH, only 9% of patients met the definition of type 1 VWD.
CONCLUSIONS: ISTH criteria failed to identify the majority of children and adolescents who presented to medical attention with significant mucocutaneous bleeding. Further work is needed to develop diagnostic criteria with improved clinical validity in the pediatric setting.

Entities:  

Mesh:

Year:  2009        PMID: 18816699     DOI: 10.1002/pbc.21755

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  3 in total

1.  Bleeding disorders, menorrhagia and iron deficiency: impacts on health-related quality of life.

Authors:  C Rae; W Furlong; J Horsman; E Pullenayegum; C Demers; J St-Louis; D Lillicrap; R Barr
Journal:  Haemophilia       Date:  2012-09-21       Impact factor: 4.287

2.  Applicability of 2009 international consensus terminology and criteria for immune thrombocytopenia to a clinical pediatric population.

Authors:  Rachael F Grace; Michelle Long; Leslie A Kalish; Ellis J Neufeld
Journal:  Pediatr Blood Cancer       Date:  2011-06-14       Impact factor: 3.167

3.  von Willebrand's disease: a report from a meeting in the Åland islands.

Authors:  E Berntorp; I Peake; U Budde; M Laffan; R Montgomery; J Windyga; A Goodeve; P Petrini; M von Depka; W Miesbach; D Lillicrap; A B Federici; R Lassila; G White
Journal:  Haemophilia       Date:  2012-09       Impact factor: 4.287

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.